Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development

被引:0
|
作者
Yanying Huo
Pier Selenica
Amar H. Mahdi
Fresia Pareja
Kelly Kyker-Snowman
Ying Chen
Rahul Kumar
Arnaud Da Cruz Paula
Thais Basili
David N. Brown
Xin Pei
Nadeem Riaz
Yongmei Tan
Yu-Xiu Huang
Tao Li
Nicola J. Barnard
Jorge S. Reis-Filho
Britta Weigelt
Bing Xia
机构
[1] Rutgers Cancer Institute of New Jersey,Department of Radiation Oncology
[2] Rutgers Robert Wood Johnson Medical School,Department of Pathology
[3] Memorial Sloan Kettering Cancer Center,Department of Radiation Oncology
[4] Memorial Sloan Kettering Cancer Center,Department of Pathology and Laboratory Medicine
[5] Stomatological Hospital of Guangzhou Medical University,Department of Physiology, College of Medicine
[6] The First Affiliated Hospital of Fujian Medical University,Centre for Brain Research
[7] Rutgers Robert Wood Johnson Medical School,undefined
[8] Al-Mustansiriyah University,undefined
[9] Indian Institute of Science (IISc),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Inherited mutations in BRCA1, BRCA2, and PALB2 cause a high risk of breast cancer. Here, we conducted parallel conditional knockout (CKO) of Brca1, Palb2, and Brca2, individually and in combination, along with one copy of Trp53, in the mammary gland of nulliparous female mice. We observed a functional equivalence of the three genes in their basic tumor-suppressive activity, a linear epistasis of Palb2 and Brca2, but complementary roles of Brca1 and Palb2 in mammary tumor suppression, as combined ablation of either Palb2 or Brca2 with Brca1 led to delayed tumor formation. Whole-exome sequencing (WES) revealed both similarities and differences between Brca1 and Palb2 or Brca2 null tumors. Analyses of mouse mammary glands and cultured human cells showed that combined loss of BRCA1 and PALB2 led to high levels of reactive oxygen species (ROS) and increased apoptosis, implicating oxidative stress in the delayed tumor development in Brca1;Palb2 double CKO mice. The functional complementarity between BRCA1 and PALB2/BRCA2 and the role of ROS in tumorigenesis require further investigation.
引用
收藏
相关论文
共 50 条
  • [41] Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
    Takeuchi, Shoko
    Doi, Manami
    Ikari, Naoki
    Yamamoto, Masakazu
    Furukawa, Toru
    SCIENTIFIC REPORTS, 2018, 8
  • [42] Plasticity of BRCA2 Function in Homologous Recombination: Genetic Interactions of the PALB2 and DNA Binding Domains
    Siaud, Nicolas
    Barbera, Maria A.
    Egashira, Akinori
    Lam, Isabel
    Christ, Nicole
    Schlacher, Katharina
    Xia, Bing
    Jasin, Maria
    PLOS GENETICS, 2011, 7 (12):
  • [43] Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
    Alicja Ogrodniczak
    Janusz Menkiszak
    Jacek Gronwald
    Joanna Tomiczek-Szwiec
    Marek Szwiec
    Cezary Cybulski
    Tadeusz Dębniak
    Tomasz Huzarski
    Aleksandra Tołoczko-Grabarek
    Tomasz Byrski
    Katarzyna Białkowska
    Karolina Prajzendanc
    Piotr Baszuk
    Jan Lubiński
    Anna Jakubowska
    Hereditary Cancer in Clinical Practice, 20
  • [44] Screening for Genetic Mutations in BRCA1 and BRCA2
    Narod, Steven
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1365 - 1365
  • [45] The Brca1 and Brca2 proteins and tumor pathogenesis
    Ingvarsson, S
    ANTICANCER RESEARCH, 1999, 19 (4B) : 2853 - 2861
  • [46] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Behl, Supriya
    Hamel, Nancy
    de Ladurantaye, Manon
    Lepage, Stephanie
    Lapointe, Rejean
    Mes-Masson, Anne-Marie
    Foulkes, William D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Identification of BRCA1 and BRCA2 genetic modifiers
    Weyandt, J. D.
    Snyder, C.
    Lynch, H. T.
    Gillanders, E.
    Holmes, T. N.
    Bailey-Wilson, J.
    Ellsworth, R. E.
    CANCER RESEARCH, 2009, 69 (02) : 117S - 118S
  • [48] Genetic counseling for BRCA1/BRCA2 testing
    Rossi, E.
    Rosania, C.
    Ventruto, M. L.
    Serrao, S.
    Colantuoni, G.
    Iannace, C.
    Russo, G.
    Buono, M.
    Gridelli, C.
    ANNALS OF ONCOLOGY, 2017, 28 : 80 - 80
  • [49] Genetic counseling for BRCA1/BRCA2 testing
    Schneider, KA
    GENETIC TESTING, 1997, 1 (02): : 91 - 98
  • [50] Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma
    Govoni, Veronica Mollica
    Da Silva, Tereza Cristina
    Guerra, Juliana Mariotti
    Pereira, Isabel Veloso Alves
    Queiroga, Felisbina Luisa
    Cogliati, Bruno
    VETERINARY AND COMPARATIVE ONCOLOGY, 2021, 19 (02) : 404 - 408